ATXA is focusing on late-stage preclinical & clinical development of novel small molecule drugs to treat Pulmonary Arterial Hypertension.

Therapeutics

Pharmaceutical

ATXA Therapeutics

ATXA Therapeutics' headquarters in Blackrock, Ireland

Therese Kinsella

Eamon Mulvaney

Helen Reid

Andy Baxter

Mark Maginn

Diarmuid Burke

Mike Perkins

Daniel O'Mahony

Adriaan Fruijtier

Jonathan Langley

This department provides expert guidance and support to clients and internal stakeholders.

Advisory Services

This department provides strategic guidance and oversight for the organization.

Executive Leadership

The Scientific Team at ATXA Therapeutics is dedicated to advancing the late-stage preclinical and clinical development of innovative small molecule drugs for treating Pulmonary Arterial Hypertension. Comprising Senior Scientist, Program Manager & Scientist, and Research Scientist, the team conducts rigorous research, designs and manages experimental protocols, and ensures seamless progression from preclinical trials to clinical applications.

ATXA Therapeutics

Org chart

Board & advisors

Teams

Advisory Services

Executive Leadership

Scientific Team

Offices

ATXA Therapeutics

Org chart

Board & advisors

Teams

Advisory Services

Executive Leadership

Scientific Team

Offices

Related companies